CompletedNot Applicable

Evaluating Cancer Survivorship Care Models

United States991 participantsStarted 2013-07

Plain-language summary

The Evaluating Cancer Survivorship Care Models project is an innovative 3-year study that is collecting data to help understand how to best deliver follow-up care to cancer survivors. Cancer is a complex disease requiring complex treatments that can cause lasting impacts after treatment ends. Some patients face physical, psychosocial, spiritual and/or practical challenges as they adjust to life after cancer. Fortunately, health care providers have begun to focus on the consequences of cancer and its treatment and are more actively working with cancer survivors to manage post-treatment needs and care. Led by the George Washington University and funded by the Patient-Centered Outcomes Research Institute, this project brings together representatives from the Commission on Cancer, the Cancer Support Community, LIVESTRONG and the American Cancer Society as well as cancer survivors and healthcare professionals to better understand how different strategies or models of care impact outcomes that are most important to cancer survivors. The project will focus on survivors of breast, prostate and colorectal cancers and will be relevant for understanding the needs and preferences of survivors of other cancers as well. The emphasis is on patient-centered outcomes, which are outcomes that are most significant to patients, such as patient satisfaction and quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * English-speaking survivors of non-metastatic breast, prostate or colorectal cancers * Completed active treatment (chemotherapy, radiation, and/or surgery), but may be on hormonal medication, aromatase inhibitors or other maintenance therapy * Diagnosed at 18 years old or older * First survivorship care appointment has been scheduled but not completed * Be a patient at one of the high-performing cancer programs selected to participate in the CER study Exclusion criteria * Diagnosed with cancer other than breast, prostate or colorectal cancer * Not English-speaking * Currently undergoing active treatment (defined as chemotherapy, radiation, and/or surgery) * Cancer has metastasized * Diagnosed at under 18 years old * Have completed first appointment with the survivorship program * Not a patient at one of the high-performing cancer programs selected to participate in the CER study

What they're measuring

Percentage of Survivors Reporting "Yes Definitely" Across Items Within Each of 9 Factors Reflecting Survivorship Care Quality

Timeframe: Patients complete a survey within one week after their survivorship visit, and 6 months post visit.

Average Number of Quality of Life Top Concerns Reported Converted to a Percentage

Timeframe: Patients complete a survey at baseline before their survivorship visit, and 6 months post visit.

Self- Efficacy Score

Timeframe: Patients complete a survey at baseline before their survivorship visit, within one week after their survivorship visit, 3 months post visit, and 6 months post visit.

Frequency of Visit

Timeframe: Patients complete a survey at baseline before their survivorship visit, 3 months post visit, and 6 months post visit.

Trial details

NCT IDNCT02362750

SponsorGeorge Washington University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-10

Results submitted2018-03-19

View on ClinicalTrials.gov More Quality of Life trials